Olga Ivanova

Dr. Olga Ivanova


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in International Journal of Circumpolar Health
Verified
Journal Article
Open access
SSSvetlana Semenovna Shadrina
Svetlana Semenovna Shadrina
ASAnna Innokentievna Sivtseva
Anna Innokentievna Sivtseva
ESElena Nikolaevna Sivtseva
Elena Nikolaevna Sivtseva
ADAra Andreevna Donskaya
Ara Andreevna Donskaya
OIOlga Ivanova
Olga Ivanova
The urgency of the problem under study is determined by the high prevalence of arterial hypertension among the indigenous minorities of the North in modern socio-economic conditions. The following article is aimed to evaluate the prevalence of behavioural arterial hypertension risk factors according to the results of single-step epidemiological research of Evenk people in the Republic of Sakha (Yakutia), Russian Federation. The leading approach to the study of this problem was the questioning of the population using the international questionnaire for behavioural risk factors (CYNDI). As a result of research, widespread smoking was found among native population (52.0% of men and 23.7% of women). The frequency of alcohol consumption among the male Evenki is comparable to that in the Yakut population, and among the female, the number is much lower. Evenks including young men belong to the physically inactive population. The frequency of arterial hypertension (AH) cases along with the factors listed above are significantly influenced by: marital status, employment, education, and housing conditions. Article materials may be useful for a differentiated approach in the development of prevention and rehabilitation programs for the indigenous peoples of the North.

28 September 2025 in Russian Journal of Immunology
Verified
Journal Article
Open access
PDF file
OIOlga Ivanova
Olga Ivanova
IIIrina S. Ivanova
Irina S. Ivanova
Prevalence of SOPH syndrome in the Republic of Sakha (Yakutia) is slightly more than 18 patients per 100,000 Yakut population. Frequency of heterozygous state for the causal mutation is 1,300 per 100,000 healthy Yakuts. As of 2009, the prevalence of SOPH syndrome in the Republic of Sakha (Yakutia) for entire population was 4.53 per 100,000, and among Yakuts, 9.95 per 100,000. This article concerns two clinical cases of SOPH syndrome in a single family (brother and sister) observed for 6 years. This clinical example is of interest to pediatricians and family doctors practicing in the Republic of Sakha (Yakutia). We used outpatient cards of municipal polyclinics for 112,000 children at their residence place, observation cards for children at the Consultative Polyclinic No.1 at the National Center of Medicine. The phenotype of both children is similar. When looking for dysplastic features, we revealed brachycephalic skull, symmetrical face, hypomimia, straight nose with protruding glabella, slight exophthalm, hypoplastic cheekbones, long filter, thin lips, uneven dentition. The skin was dark and dry. Micromelia was also documented, along with short chest and enlarged belly. The limbs were symmetrically shortened. Sex features were by male type. Stools and diuretic functions were normal. Both children underwent radiography of their hands. The delayed bone growth was revealed in both children. Both children underwent KREC and TREC studies and genetic testing. Both children were homozygous for 5741GA mutation in NBAS gene. Immunograms of both children showed a sharp decrease in IgA, IgM and IgG levels. Both children were administered regular replacement therapy with subcutaneous injections of normal human immunoglobulin. Cutaquig preparation has been also prescribed at a monthly dose of 0.5-0.6 g/kg, according to the protocol (4 g every 10 days, at two subcutaneous injection points). Currently, the children are receiving substitution therapy at their place of residence. These cases are of interest to practitioners and scientists, due to similar gene mutation in brother and sister. One should evaluate clinical course in all cases of SOPH syndrome in order to develop appropriate clinical recommendations. Establishment of the SOPH-syndrome registry in Republic of Sakha (Yakutia) will help in providing medical drugs and medical care to children with this type of primary immunodeficiency.

6 August 2024 in Russian Journal of Immunology
Verified
Journal Article
Open access
PDF file
OIOlga Ivanova
Olga Ivanova
III. S. Ivanova
I. S. Ivanova
The present study concerns clinical effects of speleotherapy in bronchial asthma. The aim of our work was to study the efficiency of speleotherapy in a group of patients with bronchial asthma. We observed a group of 51 patients with bronchial asthma (BA) aged 18 to 50 years, who received a course of treatment at the private center “Solevik” (Yakutsk City), carried out at the Department of Allergology and Immunology. All the examined patients were diagnosed with atopic bronchial asthma, of moderate severity. Basic therapy in all cases included Symbicort and Seretide treatment. The patients were managed and monitored before and after the course of treatment by a therapist, pulmonologist and allergologist-immunologist at the outpatient center. Laboratory parameters included general blood tests and the levels of total serum IgE. Examination of patients after a course of speleotherapy revealed disappearance and reduction of asthma attacks (up to 1 attack per month) in 80% of the examined. General blood testing before and after speleotherapy showed decreased levels of blood eosinophils after the course of treatment. I.e., the average initial level of blood eosinophils before treatment was 12±0.4%, being decreased after the course of speleotherapy to 5.5±0.2%. Measurements of total IgE before and after speleotherapy revealed the following results: in patients before therapy, the average level of this index was 500±0.8 units/mL. After a course of speleotherapy, this parameter decreased to 80±0.3 units/ mL. Speleotherapy shows a positive effect on the clinical course of the patients with bronchial asthma and significantly increases the efficiency of treatment.

29 December 2023 in Актуальные проблемы медицины
Verified
Journal Article
Open access
СУСеверо-Восточный Федеральный Университет
Северо-Восточный Федеральный Университет
OIOlga Ivanova
Olga Ivanova
ИИИрина Семеновна Иванова
Ирина Семеновна Иванова
В статье проведен анализ эффективности применения препарата имудон в лечении данного заболевания. Обследовано 100 детей с рецидивирующими афтозными стоматитами в течение 1 года на базе Консультативной поликлиники РБ № 1 НЦМ. У всех детей выявлено снижение иммунитета, сдвиги в общем анализе крови. Далее была выделена группа детей с рецидивирующими стоматитами – 50 детей, все они кроме местной терапии (прижигание язв стоматофитом) получали лечение препаратом имудон – обследуемая группа. Группа детей (50 человек) получали только местное лечение – контрольная группа. В лечении рецидивирующих стоматитов помимо местного лечения рекомендуется проведение терапии препаратом имудон.

22 September 2025 in Yakut Medical Journal
Verified
Journal Article
Open access
PDF file
AAA. V. Aleksandrova
A. V. Aleksandrova
OIOlga Ivanova
Olga Ivanova
ESE. N. Sivtseva
E. N. Sivtseva
LNL. A. Nikolaeva
L. A. Nikolaeva
Among the 200 adolescents aged 12 to 17 years examined, iron deficiency anemia was detected in 28% and latent iron deficiency in 30%. The presence of anemia was confirmed by laboratory indicators. Risk factors for the development of iron deficiency anemia in girls were heavy and prolonged menstruation, fasting, refusal to eat meat, intense physical activity, gastritis and colitis, and in boys pubertal growth spurt, intense physical activity, refusal to eat meat.

12 August 2024 in Russian Journal of Immunology
Verified
Journal Article
Open access
PDF file
OIOlga Ivanova
Olga Ivanova
III. S. Ivanova
I. S. Ivanova
The article is devoted to the study of the causes of the formation of allergic diseases in patients with HIV infection on the example of a clinical case. Patient C., 35 years old, was under medical supervision at the Victory Clinic from 2013 to 2015 with manifestations of skin allergies. Over the next four years, the patient received therapy for exacerbation of atopic dermatitis, followed a diet with the exception of dairy products and beef. The patient’s condition could be assessed as satisfactory; relapses of atopic dermatitis were noted 2 times after a violation of the diet. In 2017, after an unprotected contact, the patient noticed: weakness, weight loss, dry skin and enlarged peripheral lymph nodes. In June 2017, the patient turned to the district pediatrician, who prescribed a referral for a general blood and urine test, a blood test for AIDS and hepatitis. As a result of the examination, the patient was diagnosed with HIV infection. The patient was examined and treated at the Yakutsk AIDS center. Since August 2017, the patient has been worried about nasal congestion, sneezing, watery eyes, and headaches. In early September 2017, the patient turned to an allergist-immunologist. An examination was conducted: a blood test was taken for allergoscreen panel No. 1 and an immunogram, rhinocytogram. The following results were obtained: according to allergoscreen No. 1, allergy to birch 3.0, milk 3.2, wheat flour 2.8. Rhinocytogram data from 09/28/2017: neutrophils 67 per-field and eosinophils 10 per-field. People infected with the human immunodeficiency virus (HIV) have high levels of allergic conditions, including allergic rhinitis (hay fever), drug allergies and asthma. The HIV virus infects and destroys CD4+T cells, a type of white blood cell. This leads to a change in immune function, which contributes to the development of allergies, infections, cancer and other immune problems. In a patient with HIV infection, after the pathology is detected, the formation and transformation of allergic diseases is observed. The formation of allergopathology in HIV patients is associated with a reduced level of CD4+ cells, which is one of the factors contributing to the development of allergy transformation. The treatment of allergic diseases such as: bronchial asthma, atopic dermatitis, allergic rhinitis and allergic urticaria in patients with HIV is the same as in patients not infected with HIV. Oral administration of glucocorticosteroids should be avoided due to the immunosuppressive effects of this group of drugs.